companydata.dkREFLAB ApS: Financial statements 2014
CVR: 15322586
REFLAB ApS (CVR 15322586) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,638,963 and a net result of DKK 1,080,544 compared with DKK 98,128 the year before. That is an increase of 26.8% compared with the year before. Equity amounted to DKK 3,861,471. The solvency ratio was 76.2%.
- Gross Profit
- 4,638,963 kr.
- Profit/Loss
- 1,080,544 kr.
- Equity
- 3,861,471 kr.
- Total Assets
- 5,069,805 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.6 mio. | 1.1 mio. | 3.9 mio. | - |
| 2013 | - | 3.7 mio. | 98 t. | 2.8 mio. | - |
| 2012 | - | 2.5 mio. | -65 t. | 2.7 mio. | - |
Keep an eye on REFLAB ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
REFLAB ApS has published its annual report for 2013. Gross profit came to DKK 3,659,419, and the net result was DKK 98,128.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen. The company is owned by R-Biopharm AG. The company has 7 employees. In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity amounted to DKK -635,048.